Harm reduction evidence: Eastern Europe and Central Asia Raminta Stuikyte Central and Eastern European Harm Reduction Network.

Slides:



Advertisements
Similar presentations
Unprevented and prevented HIV cases in Europe and Central Asia Unprevented and prevented HIV cases in Europe and Central Asia Ani SHAKARISHVILI, MD UNAIDS.
Advertisements

The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
Bringing Opioid Substitution Treatment to scale Dr. M. Suresh Kumar Inter-country Consultation on Preventing HIV among IDUs Scaling Up: From Evidence to.
Supporting community action on AIDS in developing countries NO voice NO programs: V ulnerable communities in the EECA region Developed in collaboration.
National AIDS Control Programme 1. National AIDS Control Programme (NACP) launched under Ministry of Health & Family Welfare in 1992 NACP I (1992 – 1999)
“Humanitarian Action” The Saint-Petersburg Charitable Foundation for Medical and Social Programs HAF.
Aimed at Key Affected Population Groups.  Clinical social franchising is a model for organizing networks of private providers  to deliver a range of.
Doing the Right Thing Karen A. Stanecki XV International AIDS Conference.
Slide 5.1 Topic 5. Supporting programs aimed at reducing the spread of HIV among and from IDU Needle and Syringe Programs Opioid Substitution Treatment.
…at what cost ? …at what cost ?. Ten year review:  Law enforcement at the expense of public health and human rights  Major HIV epidemics among IDU 
Drug policy and harm reduction: impact of the US policy Raminta Stuikyte Central and Eastern European Harm Reduction Network.
Overview of Syringe Exchange Programs New York City Police Academy November 24, 2004.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
 Insufficient Reliable data in this region  Estimated people living with HIV  The number of new HIV infections in the region increased.
HIV/AIDS in Prison Settings Dr. Monica Beg HIV/AIDS Unit, United Nations Office on Drugs and Crime, Krakow, Poland September 27, 2004.
HIV and drug prevention in Estonia Harm reduction services
30 June – 03 July 2013 – Kuala Lumpur, Malaysia
HIV, Drug Policy and Harm Reduction. Outreach in Moscow, Russia,1998.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.
Advocating for Harm Reduction: A Public Health Response to Drug Use and HIV in Eastern Europe and Central Asia Sue Simon International Harm Reduction Development.
TI for IDUs Sexual IDUBlood Perinatal Unidentified Routes of HIV Transmission SENTINEL SURVEILLANCE 2006 HIV infection in India.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Key Affected Populations.
Medical Professionalism and its Relationship to Public Health: Physician Advocacy and State Public Health Policy Thomas Kellogg Program Officer and Advisor.
HIV and AIDS Data Hub for Asia-Pacific HIV and AIDS Data Hub for Asia-Pacific Review in slides China 1.
If I ruled the world… Presentation to Prisons and Beyond NOMS Prison Drug Strategy Unit, in association with the Federation of Drug & Alcohol Professionals.
A global perspective on scaling up harm reduction 2 nd National Harm Reduction Conference, Ukraine, March 2007 Dr Jos Perriens, Director Prevention.
Work group #2 Community based services and information.
Washington D.C., USA, July 2012www.aids2012.org Human rights as a key component of harm reduction strategy targeting people using drugs in Morocco.
Economic and policy dimensions of HIV in Eastern Europe and Central Asia David Wilson and Nicole Fraser, Global HIV/AIDS Program, World Bank David Wilson,
Return on investment: How do whole societies benefit from improved services and coverage for key populations? Bradley Mathers Kirby Institute UNSW Australia.
Country gallery Malaysia. Basic socio-demographic indicators, Total population (thousands)26,572 Surface area329,847 sq. km Annual population.
National roll-out of database for HIV prevention programmes among civil society organizations in Ukraine Olga Varetska ICF “International HIV/AIDS Alliance.
Paradoxes and Problems in Preventing HIV Infection among Injecting Drug Users and Their Sexual Partners in Eastern Europe and Asia Don C. Des Jarlais,
AIDS Epidemic Update December /06 e. AIDS Epidemic Update December /06 e TOTAL North America Eastern Europe & Central Asia Latin America.
‘Gaps in the global HIV/AIDS success story Copenhagen December 2 nd 2013 Gaps in the global HIV/AIDS success story Briefing on HIV/AIDS in Europe Martin.
Harm Reduction International
School of Public Health and Community Medicine How policies and repressive law- enforcement fuel the HIV epidemic among people who inject drugs Professor.
How to improve law enforcement knowledge about HIV and to work with drug users and sex workers: experiences from Kyrgyzstan Aleksandr Zelichenko, Director.
HIV vulnerabilities of sex workers in Europe
Integration of collaborative TB/HIV activities with harm reduction services Maryna Zelenskaya Ph D State service on HIV/AIDS and other socially diseases.
HIV and AIDS Data Hub for Asia-Pacific Review in slides India.
India Last updated: January 2016.
HIV/AIDS in Eastern Europe Setting the Stage for Prevention HIV/AIDS in Eastern Europe Setting the Stage for Prevention Thomas E. Novotny, MD, MPH April.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: January 2016.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Myanmar Last Update: June 2015.
From evidence to commitment to action: implementing HIV prevention measures in prisons in Ukraine XVI International AIDS Conference Toronto, 15 August.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Myanmar Last Update: April 2016.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan.
High Coverage of Most-at-Risk Populations Reduces HIV Risk: Results from Central Asia Anna Deryabina, David S. Hausner, Bibigul Aubakirova, Yana Dobronravova,
ARV Treatment Scale Up: Progress in Ukraine Andriy Klepikov Executive Director, International HIV/AIDS Alliance in Ukraine ARV Treatment Scale Up: Progress.
Monitoring of Pharmaceutical Supply in Countries of Eastern Europe, Central Asia and Caucasus Anna Żakowicz European AIDS Treatment Group Presented at.
Controlling HIV/AIDS in Russia: Strategic Chokepoints & Opportunities Olusoji Adeyi Health Program Team Leader for Russia The World Bank, Washington, DC.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: November 2014.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Riga, 29 May 2008 Sintija Šmite, UNODC.
Harm reduction saves the lives of millions: will Eastern Europe take the chance? Andriy Klepikov, Intenational HIV/AIDS Alliance in Ukraine 24 th of June,
International Harm Reduction Development Program: Lessons learned
MODULE 3 Harm reduction advocacy
Fabienne Hariga Senior Adviser, HIV/AIDS Section
The HIV/AIDS and drug use crisis in Eastern Europe and Central Asia
Eurasian Harm Reduction Network (EHRN)
The analysis and advocacy (A2) project: Role in translating Thailand’s national AIDS strategy into provincial implementation plans S. Pantuwatana1, S.
Pakistan Last updated: July 2015.
Addressing Drug Use Together Through a Health Based Approach:
Key Affected Populations
People who inject drugs
The HIV Epidemic among People who Inject Drugs
Cumulative reported HIV infections per million population
Annual newly diagnosed HIV infections per million population
Myanmar Last Update: November 2014.
Key Affected Populations
Presentation transcript:

Harm reduction evidence: Eastern Europe and Central Asia Raminta Stuikyte Central and Eastern European Harm Reduction Network

Eastern Europe and Central Asia Fast epidemics among injecting drug users; up to 75% of all registered HIV cases Drug policies could be indicated as harsh: –attached to incarceration for possession of drugs for personal use; drug users often fair to have needles with them because of police Drug services are scarce –No country has national scale of harm reduction interventions (needle exchange, outreach work, substitution treatment neither in community, nor in prisons) –Coverage estimates varies 0-15% Research is limited; mainly RAR studies and project data analysis

Needle syringe exchange (NSE) efficacy Russia: –Behavioral 5-city research showed that level of needle sharing in one month from participating at NSE from 38% to 11% in 2002 (n=1076) Des Jarlais D et. al (2002): HIV risk behavior among participants of syringe exchange programs in central/eastern Europe and Russia; International Journal of Drug Policy: 13: Ukraine: –24% of IDUs reached by NSE do not share compared to 16% of those never attending NSE sites Yaremenko, Balakirieva (2004) Effectiveness of Harm Reduction Projects in Ukraine. Ukrainian Institute for Social Research. Kyrgyzstan: –Percent of clients reusing needles drops from 98% to <30% after start of NSP –Needle sharing drops from 68% to 14%; Estebesova. The Role of NGOs in the Implementation of Harm Reduction Programs for Drug Dependency in the Kyrgyz Republic. In Decreasing Vulnerability of Injection Drug Users of the Kyrgyz Republic: Conference Proceedings (May 2003), edited by TK Asanov. Osh, 2003.

NSE efficacy II: changes in condom use and AIDS knowledge Russia –Condom use in last sexual intercourse ranges from 28% among non clients of NSE to 58% among NSE clients RAR in Russia; Open Health Institute 2003 Kyrgyzstan –Condom use increased from 14% to 46%; –Knowledge about AIDS increased from 35% to 73% Estebesova. The Role of NGOs in the Implementation of Harm Reduction Programs for Drug Dependency in the Kyrgyz Republic. In Decreasing Vulnerability of Injection Drug Users of the Kyrgyz Republic: Conference Proceedings (May 2003), edited by TK Asanov. Osh, 2003.

NSE Effectiveness III: Cost analysis Belarus –Economic evaluation of a harm reduction program in Svetlogorsk: one HIV infection could be averted for not more than US$68 Kumaranayake L et al. The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus: Draft. Geneva, UNAIDS, Russia –US$23,4 – costs per client served and $0,36 costs per syringe exchanged Bobrik A. et al. HIV prevention among drug users in Russian cities: cost-effectiveness analysis: Russian Family Doctor, 4(6)30-36

Substitution treatment Evidence even more limited as limited and mainly delayed application of substitution treatment in the region –Baltics – since ; Kyrgyzstan – since 2002; Moldova – since 2004; Ukraine, Georgia – 2005, Uzbekistan 2006 Positive preliminary results about methadone program in Lithuania: –In conclusion, there is documented evidence on the efficacy, feasibility, safety and acceptability of methadone programs in Indonesia, Lithuania and Thailand. WHO (2005) The WHO Collaborative Study on Substitution Therapy of Opioid Dependence and HIV/AIDS. Preliminary results of study implementation in Indonesia, Lithuania, and Thailand

Substitution treatment Kyrgyzstan –In Bishkek, percent of patients using opiates in addition to methadone decreases from 44% in June 2002 to 15% in April 2003 –In Osh, decrease from 25% to <5% –Only one HIV infection reported among program clients and the person was not tested on opiates by 2003 Asanov, TK. “Methadone Maintenance Treatment Programs in the Kyrgyz Republic.” In Decreasing Vulnerability of Injection Drug Users in the Kyrgyz Republic: Conference Proceedings (May 2003), edited by TK Asanov. Osh, 2003.

Summary NSE showed being effective in reducing sharing needles in different sites of Eastern Europe Some studies showed increased condom use and HIV knowledge among NSE clients NSE is cost-effective and relatively low cost Substitution treatment studies are limited and not completed, however their preliminary results indicate positive results in its efficacy in decreasing illegal opioids, decreasing injecting and needle sharing